We believe this site might serve you best:

United States

United States

Choose language: English

Promega's Cookie Policy

Our website uses functional cookies that do not collect any personal information or track your browsing activity. When you select your country, you agree that we can place these functional cookies on your device.

Anti-ACTIVE® MAPK pAb, Rabbit, (pTEpY)

Preferentially Detects Active, Dually Phosphorylated MAPK

  • Affinity-purified rabbit IgG
  • Use for Western blotting, immunocytochemistry and Immunohistochemistry

Size

Catalog number selected: V8031

$ 425.00 Your price: Log In

Add to Helix
Anti-ACTIVE® MAPK pAb, Rabbit, (pTEpY)
40μl
$ 425.00
Your price: Log In

Anti-ACTIVE® MAPK pAb is a polyclonal rabbit antibody that preferentially detects the dually phosphorylated, active form of the mitogen-activated protein kinase (MAPK) enzymes (ERK1 and ERK2). The antibody is affinity purified using a dually phosphorylated peptide that corresponds to the active form of the mitogen-activated protein (MAP) kinase enzymes.

When used at the recommended 1:5,000 dilution, this product will generate 200ml of blotting solution, sufficient for 20 Western blots of 10ml each.

  • Immunogen: Dually phosphorylated Thr/Glu/Tyr region (pTEpY) derived from the catalytic core of the active form of the mitogen-activated protein kinase (MAPK) enzymes, ERK1 and ERK2, which corresponds to Thr183 and Tyr185 of the mammalian ERK2 enzyme.
  • Antibody Form: Affinity-purified rabbit IgG; supplied in PBS (pH 7.4).
  • Working Dilutions: Western blotting (1:5,000); Immunocytochemistry (1:500); Immunohistochemistry (1:500).

Specifications

What's in the box?

Item Part # Size

Anti-ACTIVE® MAPK pAb, Rabbit, (pTEpY)

V803A 1 × 40μl

SDS

Choose language:

Certificate of Analysis

Search for Specific Certificate:

View more results
View more results
Loading…

Use Restrictions

For Research Use Only. Not for Use in Diagnostic Procedures.

Storage Conditions

BB

Store at –20°C.

Choose your country

Americas

Brazil
Canada
United States

Pacific Asia

Australia
India
Japan
Korea, Republic of
Singapore

Europe

Austria
Belgium
Denmark
Estonia
Finland
France
Germany
Iceland
Italy
Luxembourg
Netherlands
Norway
Poland
Spain
Sweden
Switzerland
United Kingdom